Agilent Technologies ROA 2010-2025 | A
Current and historical return on assets (ROA) values for Agilent Technologies (A) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Agilent Technologies ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-04-30 | $1.17B | $12.16B | 9.94% |
| 2025-01-31 | $1.26B | $11.91B | 11.04% |
| 2024-10-31 | $1.29B | $11.85B | 11.55% |
| 2024-07-31 | $1.41B | $11.00B | 12.97% |
| 2024-04-30 | $1.24B | $10.86B | 11.49% |
| 2024-01-31 | $1.24B | $10.95B | 11.45% |
| 2023-10-31 | $1.24B | $10.76B | 11.50% |
| 2023-07-31 | $1.13B | $10.68B | 10.56% |
| 2023-04-30 | $1.35B | $10.79B | 12.65% |
| 2023-01-31 | $1.32B | $10.92B | 12.48% |
| 2022-10-31 | $1.25B | $10.53B | 12.00% |
| 2022-07-31 | $1.33B | $10.48B | 12.66% |
| 2022-04-30 | $1.26B | $10.46B | 12.03% |
| 2022-01-31 | $1.21B | $10.33B | 11.50% |
| 2021-10-31 | $1.21B | $10.71B | 11.73% |
| 2021-07-31 | $0.99B | $10.49B | 9.85% |
| 2021-04-30 | $0.93B | $10.40B | 9.43% |
| 2021-01-31 | $0.81B | $9.67B | 8.46% |
| 2020-10-31 | $0.72B | $9.63B | 7.54% |
| 2020-07-31 | $0.69B | $9.55B | 7.28% |
| 2020-04-30 | $0.68B | $9.46B | 7.38% |
| 2020-01-31 | $0.76B | $9.50B | 8.35% |
| 2019-10-31 | $1.07B | $9.45B | 11.88% |
| 2019-07-31 | $1.07B | $8.63B | 12.20% |
| 2019-04-30 | $1.12B | $9.02B | 12.82% |
| 2019-01-31 | $1.14B | $8.95B | 13.17% |
| 2018-10-31 | $0.32B | $8.54B | 3.68% |
| 2018-07-31 | $0.30B | $8.35B | 3.48% |
| 2018-04-30 | $0.24B | $8.78B | 2.77% |
| 2018-01-31 | $0.20B | $8.70B | 2.35% |
| 2017-10-31 | $0.68B | $8.43B | 8.40% |
| 2017-07-31 | $0.63B | $8.26B | 7.93% |
| 2017-04-30 | $0.58B | $8.02B | 7.41% |
| 2017-01-31 | $0.51B | $7.87B | 6.56% |
| 2016-10-31 | $0.46B | $7.79B | 6.06% |
| 2016-07-31 | $0.48B | $7.73B | 6.31% |
| 2016-04-30 | $0.46B | $7.64B | 6.24% |
| 2016-01-31 | $0.46B | $7.30B | 6.24% |
| 2015-10-31 | $0.40B | $7.48B | 5.41% |
| 2015-07-31 | $0.28B | $7.25B | 3.36% |
| 2015-04-30 | $0.31B | $7.41B | 3.47% |
| 2015-01-31 | $0.37B | $7.52B | 3.67% |
| 2014-10-31 | $0.50B | $10.82B | 4.64% |
| 2014-07-31 | $0.69B | $10.38B | 6.48% |
| 2014-04-30 | $0.71B | $11.03B | 6.69% |
| 2014-01-31 | $0.74B | $10.64B | 7.02% |
| 2013-10-31 | $0.72B | $10.69B | 6.86% |
| 2013-07-31 | $0.94B | $10.28B | 8.92% |
| 2013-04-30 | $1.01B | $10.59B | 9.76% |
| 2013-01-31 | $1.10B | $10.65B | 10.92% |
| 2012-10-31 | $1.15B | $10.54B | 11.89% |
| 2012-07-31 | $1.02B | $9.76B | 10.90% |
| 2012-04-30 | $1.10B | $9.41B | 12.16% |
| 2012-01-31 | $1.05B | $9.10B | 11.80% |
| 2011-10-31 | $1.01B | $9.06B | 11.73% |
| 2011-07-31 | $1.02B | $8.75B | 11.55% |
| 2011-04-30 | $0.89B | $8.65B | 10.03% |
| 2011-01-31 | $0.80B | $8.04B | 9.22% |
| 2010-10-31 | $0.68B | $9.70B | 8.01% |
| 2010-07-31 | $0.42B | $9.10B | 5.20% |
| 2010-04-30 | $0.19B | $7.77B | 2.61% |
| 2010-01-31 | $-0.02B | $7.57B | -0.23% |
| 2009-10-31 | $-0.03B | $7.61B | -0.44% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $32.827B | $6.510B |
| Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.381B | 27.82 |
| Boston Scientific (BSX) | United States | $149.868B | 37.52 |
| Stryker (SYK) | United States | $143.347B | 29.97 |
| EssilorLuxottica (ESLOY) | France | $128.152B | 0.00 |
| Medtronic (MDT) | Ireland | $110.735B | 15.70 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.273B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.811B | 26.69 |
| ResMed (RMD) | United States | $37.196B | 27.94 |
| GE HealthCare Technologies (GEHC) | United States | $32.638B | 15.50 |
| Terumo (TRUMY) | Japan | $26.398B | 34.29 |
| Koninklijke Philips (PHG) | Netherlands | $21.463B | 15.06 |
| Insulet (PODD) | United States | $21.334B | 83.74 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.048B | 11.59 |
| Baxter (BAX) | United States | $15.390B | 11.49 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.627B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.442B | 22.42 |
| Lantheus Holdings (LNTH) | United States | $5.479B | 13.82 |
| Prestige Consumer Healthcare (PBH) | United States | $4.123B | 18.42 |
| Perrigo (PRGO) | Ireland | $3.643B | 9.23 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.415B | 15.55 |
| Envista Holdings (NVST) | United States | $3.202B | 26.61 |
| ICU Medical (ICUI) | United States | $3.144B | 23.18 |
| GN Store Nord (GNNDY) | Denmark | $2.272B | 18.82 |
| QuidelOrtho (QDEL) | United States | $1.896B | 13.04 |
| LeMaitre Vascular (LMAT) | United States | $1.848B | 41.30 |
| AtriCure (ATRC) | United States | $1.554B | 0.00 |
| Acuren (TIC) | United States | $1.324B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.132B | 11.49 |
| Neogen (NEOG) | United States | $1.072B | 13.72 |
| Green Thumb Industries (GTBIF) | United States | $1.042B | 23.43 |
| BioLife Solutions (BLFS) | United States | $1.008B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.968B | 12.37 |
| InMode (INMD) | Israel | $0.839B | 8.46 |
| Kestra Medical Technologies (KMTS) | United States | $0.772B | 0.00 |
| CeriBell (CBLL) | United States | $0.647B | 0.00 |
| Evolus (EOLS) | United States | $0.598B | 0.00 |
| Owens & Minor (OMI) | United States | $0.567B | 4.71 |
| Curaleaf Holdings (CURLF) | Canada | $0.531B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.525B | 0.00 |
| Valneva SE (VALN) | France | $0.478B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.377B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.362B | 0.00 |
| SNDL (SNDL) | Canada | $0.328B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.319B | 11.74 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.307B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.288B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.262B | 22.07 |
| Cerus (CERS) | United States | $0.256B | 0.00 |
| ZimVie (ZIMV) | United States | $0.245B | 11.13 |
| Sanara MedTech (SMTI) | United States | $0.242B | 0.00 |
| Quanterix (QTRX) | United States | $0.238B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.229B | 68.00 |
| Canopy Growth (CGC) | Canada | $0.228B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Biote (BTMD) | United States | $0.217B | 6.09 |
| Cresco Labs (CRLBF) | United States | $0.212B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.212B | 0.00 |
| Brainsway (BWAY) | Israel | $0.206B | 54.55 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| High Tide (HITI) | Canada | $0.180B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.174B | 14.19 |
| Verano Holdings (VRNOF) | United States | $0.174B | 0.00 |
| Organigram Global (OGI) | Canada | $0.173B | 0.00 |
| Exagen (XGN) | United States | $0.154B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.132B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.125B | 0.00 |
| Jin Medical (ZJYL) | China | $0.095B | 0.00 |
| Veru (VERU) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.088B | 11.34 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.083B | 0.00 |
| MacroGenics (MGNX) | United States | $0.083B | 0.00 |
| Agape ATP (ATPC) | $0.079B | 0.00 | |
| TerrAscend (TSNDF) | Canada | $0.077B | 0.00 |
| Apyx Medical (APYX) | United States | $0.076B | 0.00 |
| Zynex (ZYXI) | United States | $0.075B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| ImmuCell (ICCC) | United States | $0.069B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
| Nephros (NEPH) | United States | $0.053B | 71.43 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 12.98 |
| Rockwell Medical (RMTI) | United States | $0.030B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.019B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.011B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |